1 year return (CAGR)
-99.54%
Lyra Therapeutics Inc Exchange (NASDAQ, USD)
LYRA
0.03
-0.17 (-85.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-94.53%
5 year return (CAGR)
-85.29%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
53.25K
Price/Sales
0.13
Ent value
30.99M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-57.15%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.03 |
| Daily high | 0.20 |
| Daily low | 0.03 |
| Daily Volume | 2K |
| All-time high | 889.00 |
| 1y analyst estimate | 16.00 |
| Beta | 0.70 |
| EPS (TTM) | -1.86 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LYRA | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.38% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 20 Aug 2026 | 9 Mar 2009 |
| Avg drop from high | -75.84% | -10.68% |
| Avg time to new high | 806 days | 12 days |
| Max time to new high | 1610 days | 1805 days |
News
